View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . October 20th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Osteoporosis - Unigene Initiates Phase I Clinical Study for Oral PTH

Pain Management - Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints in Second Phase IIa Respiratory Depression Study in Germany

QLT Inc. - QLT announces the initiation of a Phase I trial of its synthetic retinoid product

Type 1 Diabetes - Diamyd(R) Study Published in Prestigious New England Journal of Medicine

Cancer Vaccines - Findings from T. Tsuruma and co-authors broaden understanding of cancer vaccines

Chromatography - New chromatography study findings have been reported by W. Hauck and colleagues

Colon Cancer - Research results from C. Oliva and co-authors update knowledge of colon cancer

Gastric Cancer - Researchers at Yokohama City University release new data on gastric cancer

HIV/AIDS - Research conducted at Brigham and Women's Hospital has updated our knowledge about HIV/AIDS

HIV/AIDS - Scientists at University of British Columbia target HIV/AIDS

HIV/AIDS - University of California details research in HIV/AIDS

Life Sciences - Research in the area of life sciences reported from P.J. Lariccia and colleagues

Myeloma - Research from Kocaeli University broadens understanding of myeloma

Pancreatic Cancer - Research from S. Ina and colleagues provide new insights into pancreatic cancer

Vasculitis - Studies from C. Metzler et al add new findings in the area of vasculitis

Breast Cancer Therapy - Data from Vanderbilt University, Vanderbilt-Ingram Comprehensive Cancer Center advance knowledge in breast cancer therapy

Controlled Release - Findings in controlled release reported from University of California

Fusion Proteins - Recent studies by E. Bouman-Thio and co-authors add new data to fusion proteins findings

Mesothelioma Quality of Care - Study findings from K. Ribi et al provide new insights into mesothelioma quality of care

Non-Small Cell Lung Cancer Therapy - Scientists at University libre of Bruxelles detail research in non-small cell lung cancer therapy

Osteoporosis Therapy - Studies from Institute for Myeloma and Bone Cancer Research add new findings in the area of osteoporosis therapy

Prostate Cancer Therapy - Study results from A.J. Armstrong and colleagues in the area of prostate cancer therapy published

Amsterdam Molecular Therapeutics B.V - AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)

Asthma - Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients

Avexa Limited - Avexa Bolsters Board of Directors and Appoints New Chairman

Breast Cancer - Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial

Cancer Vaccines - BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine

Candidiasis - CombinatorX Announces Top-Line Results from Phase 2b Study of Synavive (CRx-102) for Knee Osteoarthritis

Crohn Disease - New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

Cyclacel Pharmaceuticals, Inc. - Cyclacel Announces Completion of Enrollment in Phase 2 Trial of Sapacitabine in Elderly AML

Dysplasia - Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR

Esophagitis - Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed

FoldRx Pharmaceuticals, Inc. - FoldRx Announces Rapid Progress with Development Program for Lead Candidate

Gastroenterology - Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting

Hypertension - Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

Immunotherapy - Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial

Infantile Spasm - Marinus Pharmaceuticals, Inc., Completes Two Phase 2 Milestones for Ganaxolone in Epilepsy

Inspire Pharmaceuticals, Inc. - Inspire Initiates Phase 1 Trial of INS117548 for Glaucoma

Irritable Bowel Syndrome - Salix Presents New Phase II Data Evidence Demonstrating the Clinical Utility of Rifaximin in Irritable Bowel Syndrome (IBS); Results Presented at American College of Gastroenterology Annual Meeting Demonstrate Quality

NewsRx - NewsRx Launches New Business Titles, Offers Free Global Warming Publication

Obesity and Diabetes - Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting

Osteoporosis - Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms Separate Retrospective Analysis of Phase 3 Data Offers Additional I

Poniard Pharmaceuticals, Inc. - Poniard Pharmaceuticals Exercises Option to Draw Down $10 Million Second Tranche of Loan Facility

Salix Pharmaceuticals, Ltd. - Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal Phase 3 Study

Sosei Group Corporation - NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

Surgery - Circassia Acquires North American and Japanese Rights to Dopexamine

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx